Wendel Bruce
- SEC CIK
- 0001364846
No open-market purchases or sales filed in the past year.
Current role at each company
- IBRX ImmunityBio, Inc.Directoras of Jun 10, 2026
- GTBP GT Biopharma, Inc.Directoras of Feb 1, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Wendel Bruce as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
GTBP GT Biopharma, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 7, 2021 (view filing) | Nov 16-Dec 22, 2020 | 325 daysLate | Wendel BruceDirector | PPurchase | +5.08K | $5.17 | +$26.3K | New position5.08K after | 3 lots |